InsiderClue
Stocks · Technology · Laboratory Analytical Instruments

10x Genomics, Inc.

TXG Clue Score54
United States Fiscal year ends December CIK 0001770787
$80.65 +4.36% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $80.65 −48.31% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Sep 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue71.1Operating income−18.4Net income−18.8Fiscal year 2018Revenue146.3 +105.8%Operating income−110.8Net income−112.5Fiscal year 2019Revenue245.9 +68.1%Operating income−30.6Net income−31.3EPS, diluted−0.80Fiscal year 2020Revenue298.8 +21.5%Operating income−534.1Net income−542.7EPS, diluted−5.37Fiscal year 2021Revenue490.5 +64.1%Operating income−52.3Net income−58.2EPS, diluted−0.53Fiscal year 2022Revenue516.4 +5.3%Operating income−167.9Net income−166.0EPS, diluted−1.46Fiscal year 2023Revenue618.7 +19.8%Operating income−265.3Net income−255.1EPS, diluted−2.18Fiscal year 2024Revenue610.8 −1.3%Operating income−194.6Net income−182.6EPS, diluted−1.52Fiscal year 2025Revenue642.8 +5.2%Operating income−61.0Net income−43.5EPS, diluted−0.35
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 71.1 146.3 245.9 298.8 490.5 516.4 618.7 610.8 642.8
Growth +105.8% +68.1% +21.5% +64.1% +5.3% +19.8% −1.3% +5.2%
Operating income −18.4 −110.8 −30.6 −534.1 −52.3 −167.9 −265.3 −194.6 −61.0
Net income −18.8 −112.5 −31.3 −542.7 −58.2 −166.0 −255.1 −182.6 −43.5
Growth
EPS, diluted n/a n/a −0.80 −5.37 −0.53 −1.46 −2.18 −1.52 −0.35

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin85.1%Operating margin−25.8%Net margin−26.4%Free cash flow margin−20.3%Fiscal year 2018Gross margin80.4%Operating margin−75.7%Net margin−76.9%Free cash flow margin−56.5%Fiscal year 2019Gross margin75.2%Operating margin−12.4%Net margin−12.7%Free cash flow margin−3.3%Fiscal year 2020Gross margin80.4%Operating margin−178.7%Net margin−181.6%Free cash flow margin−85.2%Fiscal year 2021Gross margin84.9%Operating margin−10.7%Net margin−11.9%Free cash flow margin−25.0%Fiscal year 2022Gross margin76.7%Operating margin−32.5%Net margin−32.1%Free cash flow margin−32.0%Fiscal year 2023Gross margin66.2%Operating margin−42.9%Net margin−41.2%Free cash flow margin−10.3%Fiscal year 2024Gross margin67.9%Operating margin−31.9%Net margin−29.9%Free cash flow margin−0.9%Fiscal year 2025Gross margin69.1%Operating margin−9.5%Net margin−6.8%Free cash flow margin20.2%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 85.1% 80.4% 75.2% 80.4% 84.9% 76.7% 66.2% 67.9% 69.1%
Operating margin −25.8% −75.7% −12.4% −178.7% −10.7% −32.5% −42.9% −31.9% −9.5%
Net margin −26.4% −76.9% −12.7% −181.6% −11.9% −32.1% −41.2% −29.9% −6.8%
Free cash flow margin −20.3% −56.5% −3.3% −85.2% −25.0% −32.0% −10.3% −0.9% 20.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−10.7Capital expenditure−3.8Free cash flow−14.5Buybacks−0.1Fiscal year 2018Operating cash flow−76.4Capital expenditure−6.3Free cash flow−82.7Fiscal year 2019Operating cash flow34.6Capital expenditure−42.7Free cash flow−8.1Fiscal year 2020Operating cash flow−217.9Capital expenditure−36.7Free cash flow−254.6Fiscal year 2021Operating cash flow−21.4Capital expenditure−101.3Free cash flow−122.7Fiscal year 2022Operating cash flow−33.6Capital expenditure−131.7Free cash flow−165.3Fiscal year 2023Operating cash flow−15.2Capital expenditure−48.6Free cash flow−63.8Fiscal year 2024Operating cash flow6.7Capital expenditure−12.4Free cash flow−5.7Fiscal year 2025Operating cash flow136.1Capital expenditure−5.9Free cash flow130.1
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −10.7 −76.4 34.6 −217.9 −21.4 −33.6 −15.2 6.7 136.1
Capital expenditure −3.8 −6.3 −42.7 −36.7 −101.3 −131.7 −48.6 −12.4 −5.9
Free cash flow −14.5 −82.7 −8.1 −254.6 −122.7 −165.3 −63.8 −5.7 130.1
Growth
Buybacks −0.1 n/a n/a n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash47.9Shareholders’ equity−112.5Fiscal year 2018Cash65.1Total debt29.7Net cash (debt)35.4Shareholders’ equity−220.0Fiscal year 2019Cash424.2Total debt29.7Net cash (debt)394.4Shareholders’ equity420.1Debt to equity0.07Fiscal year 2020Cash663.6Total debt0.0Net cash (debt)663.6Shareholders’ equity739.1Debt to equity0.00Fiscal year 2021Cash587.4Shareholders’ equity817.6Fiscal year 2022Cash219.7Shareholders’ equity805.7Fiscal year 2023Cash359.3Shareholders’ equity741.0Fiscal year 2024Cash344.1Shareholders’ equity710.1Fiscal year 2025Cash474.0Shareholders’ equity796.3
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 47.9 65.1 424.2 663.6 587.4 219.7 359.3 344.1 474.0
Total debt n/a 29.7 29.7 0.0 n/a n/a n/a n/a n/a
Net cash (debt) n/a 35.4 394.4 663.6 n/a n/a n/a n/a n/a
Shareholders’ equity −112.5 −220.0 420.1 739.1 817.6 805.7 741.0 710.1 796.3
Debt to equity n/a n/a 0.07 0.00 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
71.1 146.3 245.9 298.8 490.5 516.4 618.7 610.8 642.8
Growth +105.8% +68.1% +21.5% +64.1% +5.3% +19.8% −1.3% +5.2%
10.6 28.7 61.0 58.5 74.1 120.4 209.4 196.3 198.9
60.5 117.7 184.9 240.4 416.4 396.0 409.3 414.5 443.9
Growth +94.4% +57.1% +30.0% +73.2% −4.9% +3.4% +1.3% +7.1%
46.7 87.9 130.8 202.3 257.6 298.3 343.3 344.3 316.1
−18.4 −110.8 −30.6 −534.1 −52.3 −167.9 −265.3 −194.6 −61.0
Growth
−18.7 −112.4 −31.0 −534.5 −53.7 −162.0 −248.8 −177.7 −39.9
0.0 0.1 0.2 8.3 4.5 4.0 6.3 4.9 3.6
−18.8 −112.5 −31.3 −542.7 −58.2 −166.0 −255.1 −182.6 −43.5
Growth
Per share
n/a n/a −0.80 −5.37 −0.53 −1.46 −2.18 −1.52 −0.35
n/a n/a −0.80 −5.37 −0.53 −1.46 −2.18 −1.52 −0.35
Growth
n/a n/a 39.1 101.2 110.3 113.9 117.2 120.5 124.7
n/a n/a 39.1 101.2 110.3 113.9 117.2 120.5 124.7
Growth +158.8% +9.1% +3.2% +2.9% +2.8% +3.6%

† The diluted share count jumps at 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 16.6% a year over five years.
  • Operating margin is up 169.2 points on five years ago, at -9.5%.
  • A net loss in 9 of 9 years on file.